nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—HTR3A—schizophrenia	0.477	0.597	CbGaD
Tapentadol—SLC6A4—schizophrenia	0.189	0.237	CbGaD
Tapentadol—CYP2D6—schizophrenia	0.133	0.166	CbGaD
Tapentadol—SLC6A2—locus ceruleus—schizophrenia	0.00791	0.107	CbGeAlD
Tapentadol—OPRM1—telencephalic ventricle—schizophrenia	0.00513	0.0691	CbGeAlD
Tapentadol—SLC6A2—autonomic nervous system—schizophrenia	0.00421	0.0567	CbGeAlD
Tapentadol—CYP2C19—urine—schizophrenia	0.00323	0.0435	CbGeAlD
Tapentadol—CYP2C9—urine—schizophrenia	0.0025	0.0337	CbGeAlD
Tapentadol—SLC6A4—blood plasma—schizophrenia	0.00203	0.0274	CbGeAlD
Tapentadol—OPRD1—forebrain—schizophrenia	0.00196	0.0265	CbGeAlD
Tapentadol—OPRK1—forebrain—schizophrenia	0.00188	0.0254	CbGeAlD
Tapentadol—CYP2D6—urine—schizophrenia	0.00188	0.0253	CbGeAlD
Tapentadol—OPRD1—telencephalon—schizophrenia	0.0018	0.0243	CbGeAlD
Tapentadol—CYP2C19—blood plasma—schizophrenia	0.00168	0.0227	CbGeAlD
Tapentadol—HTR3A—forebrain—schizophrenia	0.00146	0.0197	CbGeAlD
Tapentadol—UGT1A9—endocrine gland—schizophrenia	0.00144	0.0194	CbGeAlD
Tapentadol—Phenylephrine—MAOA—schizophrenia	0.00142	0.424	CrCbGaD
Tapentadol—HTR3A—telencephalon—schizophrenia	0.00134	0.0181	CbGeAlD
Tapentadol—OPRM1—forebrain—schizophrenia	0.00134	0.018	CbGeAlD
Tapentadol—CYP2C9—blood plasma—schizophrenia	0.00131	0.0176	CbGeAlD
Tapentadol—OPRM1—telencephalon—schizophrenia	0.00123	0.0166	CbGeAlD
Tapentadol—UGT2B7—endocrine gland—schizophrenia	0.00116	0.0156	CbGeAlD
Tapentadol—SLC6A4—forebrain—schizophrenia	0.00111	0.015	CbGeAlD
Tapentadol—Rivastigmine—CYP2D6—schizophrenia	0.00109	0.326	CrCbGaD
Tapentadol—OPRD1—nervous system—schizophrenia	0.00107	0.0144	CbGeAlD
Tapentadol—OPRD1—central nervous system—schizophrenia	0.00103	0.0138	CbGeAlD
Tapentadol—SLC6A4—telencephalon—schizophrenia	0.00102	0.0138	CbGeAlD
Tapentadol—OPRK1—nervous system—schizophrenia	0.00102	0.0138	CbGeAlD
Tapentadol—OPRK1—central nervous system—schizophrenia	0.000983	0.0133	CbGeAlD
Tapentadol—SLC6A2—forebrain—schizophrenia	0.00098	0.0132	CbGeAlD
Tapentadol—CYP2D6—blood plasma—schizophrenia	0.00098	0.0132	CbGeAlD
Tapentadol—HTR3A—blood—schizophrenia	0.000976	0.0132	CbGeAlD
Tapentadol—OPRK1—cerebellum—schizophrenia	0.000961	0.013	CbGeAlD
Tapentadol—SLC6A2—telencephalon—schizophrenia	0.000901	0.0121	CbGeAlD
Tapentadol—OPRM1—blood—schizophrenia	0.000895	0.0121	CbGeAlD
Tapentadol—OPRM1—midbrain—schizophrenia	0.000884	0.0119	CbGeAlD
Tapentadol—Phenylephrine—CYP1A2—schizophrenia	0.000836	0.249	CrCbGaD
Tapentadol—OPRD1—brain—schizophrenia	0.000814	0.011	CbGeAlD
Tapentadol—HTR3A—nervous system—schizophrenia	0.000793	0.0107	CbGeAlD
Tapentadol—OPRK1—brain—schizophrenia	0.000781	0.0105	CbGeAlD
Tapentadol—OPRM1—endocrine gland—schizophrenia	0.000776	0.0105	CbGeAlD
Tapentadol—HTR3A—central nervous system—schizophrenia	0.000763	0.0103	CbGeAlD
Tapentadol—SLC6A2—gonad—schizophrenia	0.000752	0.0101	CbGeAlD
Tapentadol—SLC6A4—blood—schizophrenia	0.000744	0.01	CbGeAlD
Tapentadol—SLC6A4—midbrain—schizophrenia	0.000735	0.00991	CbGeAlD
Tapentadol—OPRM1—nervous system—schizophrenia	0.000727	0.0098	CbGeAlD
Tapentadol—OPRM1—central nervous system—schizophrenia	0.0007	0.00943	CbGeAlD
Tapentadol—SLC6A4—endocrine gland—schizophrenia	0.000646	0.0087	CbGeAlD
Tapentadol—CYP2C19—blood—schizophrenia	0.000617	0.00832	CbGeAlD
Tapentadol—HTR3A—brain—schizophrenia	0.000606	0.00817	CbGeAlD
Tapentadol—SLC6A4—nervous system—schizophrenia	0.000604	0.00815	CbGeAlD
Tapentadol—SLC6A4—central nervous system—schizophrenia	0.000582	0.00784	CbGeAlD
Tapentadol—SLC6A2—endocrine gland—schizophrenia	0.000568	0.00766	CbGeAlD
Tapentadol—OPRM1—brain—schizophrenia	0.000555	0.00749	CbGeAlD
Tapentadol—CYP2D6—forebrain—schizophrenia	0.000537	0.00723	CbGeAlD
Tapentadol—CYP2C19—endocrine gland—schizophrenia	0.000535	0.00721	CbGeAlD
Tapentadol—SLC6A2—nervous system—schizophrenia	0.000532	0.00717	CbGeAlD
Tapentadol—SLC6A2—central nervous system—schizophrenia	0.000512	0.00691	CbGeAlD
Tapentadol—CYP2D6—telencephalon—schizophrenia	0.000493	0.00665	CbGeAlD
Tapentadol—CYP2C9—blood—schizophrenia	0.000478	0.00645	CbGeAlD
Tapentadol—SLC6A4—brain—schizophrenia	0.000462	0.00623	CbGeAlD
Tapentadol—CYP2C9—endocrine gland—schizophrenia	0.000415	0.00559	CbGeAlD
Tapentadol—SLC6A2—brain—schizophrenia	0.000407	0.00548	CbGeAlD
Tapentadol—CYP2D6—blood—schizophrenia	0.000359	0.00484	CbGeAlD
Tapentadol—CYP2D6—endocrine gland—schizophrenia	0.000311	0.0042	CbGeAlD
Tapentadol—CYP2D6—nervous system—schizophrenia	0.000291	0.00393	CbGeAlD
Tapentadol—CYP2D6—central nervous system—schizophrenia	0.00028	0.00378	CbGeAlD
Tapentadol—CYP2D6—cerebellum—schizophrenia	0.000274	0.0037	CbGeAlD
Tapentadol—CYP2D6—brain—schizophrenia	0.000223	0.003	CbGeAlD
Tapentadol—OPRM1—Signaling Pathways—TLE1—schizophrenia	2.26e-05	0.000183	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NRG3—schizophrenia	2.26e-05	0.000183	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NDST3—schizophrenia	2.25e-05	0.000182	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GFAP—schizophrenia	2.24e-05	0.000181	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NDST3—schizophrenia	2.23e-05	0.00018	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ADORA2A—schizophrenia	2.22e-05	0.00018	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—DAO—schizophrenia	2.21e-05	0.000179	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GRM5—schizophrenia	2.21e-05	0.000179	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HTR2A—schizophrenia	2.21e-05	0.000178	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CACNA1C—schizophrenia	2.2e-05	0.000178	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR1A—schizophrenia	2.2e-05	0.000178	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PLA2G4A—schizophrenia	2.19e-05	0.000177	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NPS—schizophrenia	2.17e-05	0.000175	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3C2A—schizophrenia	2.15e-05	0.000173	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CYP1A2—schizophrenia	2.14e-05	0.000173	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TLE3—schizophrenia	2.14e-05	0.000173	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ACSL6—schizophrenia	2.13e-05	0.000172	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SLC27A5—schizophrenia	2.13e-05	0.000172	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—FGA—schizophrenia	2.13e-05	0.000172	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR2A—schizophrenia	2.13e-05	0.000172	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—DRD1—schizophrenia	2.13e-05	0.000172	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR2C—schizophrenia	2.13e-05	0.000172	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PNP—schizophrenia	2.12e-05	0.000171	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SLC27A5—schizophrenia	2.11e-05	0.000171	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ACSL6—schizophrenia	2.11e-05	0.000171	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—TH—schizophrenia	2.11e-05	0.000171	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOTCH4—schizophrenia	2.08e-05	0.000168	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NPY—schizophrenia	2.08e-05	0.000168	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ATP2A2—schizophrenia	2.08e-05	0.000168	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NTRK2—schizophrenia	2.07e-05	0.000167	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	2.07e-05	0.000167	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—DRD3—schizophrenia	2.06e-05	0.000166	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—DAO—schizophrenia	2.03e-05	0.000164	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCK—schizophrenia	2.02e-05	0.000163	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—DAO—schizophrenia	2.02e-05	0.000163	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR1B—schizophrenia	2e-05	0.000162	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—OXT—schizophrenia	2e-05	0.000162	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—DRD4—schizophrenia	2e-05	0.000161	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NDUFV2—schizophrenia	1.97e-05	0.000159	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PDE4B—schizophrenia	1.97e-05	0.000159	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PNP—schizophrenia	1.95e-05	0.000158	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCKAR—schizophrenia	1.94e-05	0.000157	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR2A—schizophrenia	1.93e-05	0.000156	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PNP—schizophrenia	1.93e-05	0.000156	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR1A—schizophrenia	1.93e-05	0.000156	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP2D6—schizophrenia	1.93e-05	0.000156	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—SNAP25—schizophrenia	1.93e-05	0.000156	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CNR1—schizophrenia	1.91e-05	0.000154	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NPS—schizophrenia	1.9e-05	0.000153	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ADORA2A—schizophrenia	1.88e-05	0.000152	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR2C—schizophrenia	1.86e-05	0.000151	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DRD1—schizophrenia	1.86e-05	0.000151	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—DRD2—schizophrenia	1.86e-05	0.00015	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR7—schizophrenia	1.86e-05	0.00015	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIP4K2A—schizophrenia	1.85e-05	0.00015	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PLA2G4A—schizophrenia	1.85e-05	0.000149	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	1.84e-05	0.000148	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NDUFV2—schizophrenia	1.81e-05	0.000146	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NTRK2—schizophrenia	1.81e-05	0.000146	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DRD3—schizophrenia	1.8e-05	0.000146	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—FGA—schizophrenia	1.8e-05	0.000146	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR2A—schizophrenia	1.8e-05	0.000145	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NDUFV2—schizophrenia	1.8e-05	0.000145	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—COMT—schizophrenia	1.8e-05	0.000145	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GSTP1—schizophrenia	1.79e-05	0.000144	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MAOA—schizophrenia	1.78e-05	0.000144	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PRL—schizophrenia	1.76e-05	0.000142	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NPY—schizophrenia	1.76e-05	0.000142	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOTCH4—schizophrenia	1.76e-05	0.000142	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ATP2A2—schizophrenia	1.76e-05	0.000142	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DRD4—schizophrenia	1.75e-05	0.000142	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP1A2—schizophrenia	1.74e-05	0.000141	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—TH—schizophrenia	1.72e-05	0.000139	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIP4K2A—schizophrenia	1.7e-05	0.000138	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—OXT—schizophrenia	1.69e-05	0.000137	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR1B—schizophrenia	1.69e-05	0.000137	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ABCB1—schizophrenia	1.69e-05	0.000137	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIP4K2A—schizophrenia	1.69e-05	0.000137	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP26B1—schizophrenia	1.68e-05	0.000135	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	1.68e-05	0.000135	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CNR1—schizophrenia	1.67e-05	0.000135	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PLA2G4A—schizophrenia	1.64e-05	0.000133	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GSTM1—schizophrenia	1.64e-05	0.000133	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—S100B—schizophrenia	1.64e-05	0.000132	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR2A—schizophrenia	1.64e-05	0.000132	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR7—schizophrenia	1.63e-05	0.000132	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DRD2—schizophrenia	1.63e-05	0.000132	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR1A—schizophrenia	1.63e-05	0.000132	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NPS—schizophrenia	1.61e-05	0.00013	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DRD1—schizophrenia	1.57e-05	0.000127	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR2C—schizophrenia	1.57e-05	0.000127	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ERBB4—schizophrenia	1.57e-05	0.000127	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP26B1—schizophrenia	1.54e-05	0.000125	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PRL—schizophrenia	1.54e-05	0.000124	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NTRK2—schizophrenia	1.53e-05	0.000124	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP26B1—schizophrenia	1.53e-05	0.000123	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DRD3—schizophrenia	1.53e-05	0.000123	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TPH1—schizophrenia	1.49e-05	0.000121	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GCLM—schizophrenia	1.49e-05	0.000121	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DRD4—schizophrenia	1.48e-05	0.00012	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PLA2G4A—schizophrenia	1.47e-05	0.000119	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—COMT—schizophrenia	1.46e-05	0.000118	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GSTP1—schizophrenia	1.45e-05	0.000117	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MTHFR—schizophrenia	1.45e-05	0.000117	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MAOA—schizophrenia	1.45e-05	0.000117	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NRG1—schizophrenia	1.45e-05	0.000117	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—S100B—schizophrenia	1.44e-05	0.000116	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MEF2C—schizophrenia	1.43e-05	0.000116	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CNR1—schizophrenia	1.41e-05	0.000114	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	1.41e-05	0.000114	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.41e-05	0.000114	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PRKD1—schizophrenia	1.4e-05	0.000113	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—YWHAZ—schizophrenia	1.38e-05	0.000112	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR7—schizophrenia	1.38e-05	0.000111	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DRD2—schizophrenia	1.38e-05	0.000111	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ABCB1—schizophrenia	1.38e-05	0.000111	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TPH1—schizophrenia	1.37e-05	0.000111	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GCLM—schizophrenia	1.37e-05	0.000111	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ERBB4—schizophrenia	1.37e-05	0.000111	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TPH1—schizophrenia	1.36e-05	0.00011	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GCLM—schizophrenia	1.36e-05	0.00011	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ERBB3—schizophrenia	1.35e-05	0.000109	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—APOE—schizophrenia	1.35e-05	0.000109	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—APOA1—schizophrenia	1.34e-05	0.000108	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PLA2G4A—schizophrenia	1.33e-05	0.000108	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GSTM1—schizophrenia	1.33e-05	0.000108	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR2A—schizophrenia	1.3e-05	0.000105	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PRL—schizophrenia	1.3e-05	0.000105	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PRKD1—schizophrenia	1.29e-05	0.000104	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PLA2G4A—schizophrenia	1.29e-05	0.000104	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	1.28e-05	0.000104	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PRKD1—schizophrenia	1.28e-05	0.000103	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NRG1—schizophrenia	1.27e-05	0.000102	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MEF2C—schizophrenia	1.26e-05	0.000101	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—YWHAZ—schizophrenia	1.21e-05	9.81e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—S100B—schizophrenia	1.21e-05	9.81e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APOE—schizophrenia	1.21e-05	9.79e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APOA1—schizophrenia	1.2e-05	9.68e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ERBB3—schizophrenia	1.19e-05	9.59e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MTHFR—schizophrenia	1.18e-05	9.53e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GAPDH—schizophrenia	1.17e-05	9.47e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CLOCK—schizophrenia	1.16e-05	9.39e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ERBB4—schizophrenia	1.16e-05	9.38e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—schizophrenia	1.16e-05	9.36e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ESR1—schizophrenia	1.16e-05	9.35e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	1.15e-05	9.26e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR2A—schizophrenia	1.14e-05	9.23e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TPH2—schizophrenia	1.13e-05	9.15e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CACNB2—schizophrenia	1.13e-05	9.15e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—DPYD—schizophrenia	1.11e-05	9e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—APOE—schizophrenia	1.1e-05	8.87e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PLA2G4A—schizophrenia	1.09e-05	8.82e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—APOA1—schizophrenia	1.09e-05	8.77e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GAPDH—schizophrenia	1.08e-05	8.71e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NRG1—schizophrenia	1.07e-05	8.65e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GAPDH—schizophrenia	1.07e-05	8.63e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CLOCK—schizophrenia	1.07e-05	8.63e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APOE—schizophrenia	1.06e-05	8.58e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MEF2C—schizophrenia	1.06e-05	8.58e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CLOCK—schizophrenia	1.06e-05	8.56e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—schizophrenia	1.06e-05	8.54e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APOA1—schizophrenia	1.05e-05	8.48e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—GSK3B—schizophrenia	1.05e-05	8.48e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	1.04e-05	8.44e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TPH2—schizophrenia	1.04e-05	8.41e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CACNB2—schizophrenia	1.04e-05	8.41e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CACNA1C—schizophrenia	1.04e-05	8.36e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CACNB2—schizophrenia	1.03e-05	8.34e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TPH2—schizophrenia	1.03e-05	8.34e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—YWHAZ—schizophrenia	1.03e-05	8.29e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—DPYD—schizophrenia	1.02e-05	8.28e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—DPYD—schizophrenia	1.02e-05	8.2e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ESR1—schizophrenia	1.01e-05	8.19e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3C2A—schizophrenia	1.01e-05	8.15e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ERBB3—schizophrenia	1e-05	8.11e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR2A—schizophrenia	9.66e-06	7.8e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CACNA1C—schizophrenia	9.53e-06	7.69e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CACNA1C—schizophrenia	9.44e-06	7.63e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3C2A—schizophrenia	9.28e-06	7.5e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GSK3B—schizophrenia	9.2e-06	7.43e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3C2A—schizophrenia	9.2e-06	7.43e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SNAP25—schizophrenia	9.05e-06	7.31e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP2D6—schizophrenia	9.05e-06	7.31e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APOE—schizophrenia	8.98e-06	7.25e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APOA1—schizophrenia	8.88e-06	7.17e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ESR1—schizophrenia	8.57e-06	6.93e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SNAP25—schizophrenia	8.33e-06	6.72e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SNAP25—schizophrenia	8.25e-06	6.67e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP2D6—schizophrenia	8.25e-06	6.67e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP1A2—schizophrenia	8.19e-06	6.61e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TH—schizophrenia	8.07e-06	6.52e-05	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—AKT1—schizophrenia	7.78e-06	6.28e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GSK3B—schizophrenia	7.78e-06	6.28e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—EP300—schizophrenia	7.7e-06	6.22e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP1A2—schizophrenia	7.53e-06	6.08e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP1A2—schizophrenia	7.46e-06	6.03e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TH—schizophrenia	7.42e-06	5.99e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TH—schizophrenia	7.36e-06	5.94e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—AKT1—schizophrenia	7.06e-06	5.71e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EP300—schizophrenia	6.91e-06	5.58e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—COMT—schizophrenia	6.86e-06	5.54e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GSTP1—schizophrenia	6.83e-06	5.52e-05	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—AKT1—schizophrenia	6.82e-06	5.51e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MAOA—schizophrenia	6.81e-06	5.5e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—schizophrenia	6.61e-06	5.34e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ABCB1—schizophrenia	6.46e-06	5.22e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—COMT—schizophrenia	6.31e-06	5.1e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTP1—schizophrenia	6.28e-06	5.07e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PLA2G4A—schizophrenia	6.27e-06	5.07e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GSTM1—schizophrenia	6.27e-06	5.07e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MAOA—schizophrenia	6.27e-06	5.06e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—EP300—schizophrenia	6.26e-06	5.06e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—COMT—schizophrenia	6.26e-06	5.05e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTP1—schizophrenia	6.23e-06	5.03e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MAOA—schizophrenia	6.21e-06	5.02e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—AKT1—schizophrenia	6.19e-06	5e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EP300—schizophrenia	6.06e-06	4.89e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	6.02e-06	4.87e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ABCB1—schizophrenia	5.94e-06	4.8e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ABCB1—schizophrenia	5.89e-06	4.76e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PLA2G4A—schizophrenia	5.77e-06	4.66e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTM1—schizophrenia	5.77e-06	4.66e-05	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—AKT1—schizophrenia	5.77e-06	4.66e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PLA2G4A—schizophrenia	5.72e-06	4.62e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTM1—schizophrenia	5.72e-06	4.62e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MTHFR—schizophrenia	5.55e-06	4.48e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—AKT1—schizophrenia	5.24e-06	4.23e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOE—schizophrenia	5.16e-06	4.17e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EP300—schizophrenia	5.12e-06	4.13e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOA1—schizophrenia	5.1e-06	4.12e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MTHFR—schizophrenia	5.1e-06	4.12e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MTHFR—schizophrenia	5.06e-06	4.08e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TP53—schizophrenia	4.94e-06	3.99e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOE—schizophrenia	4.75e-06	3.84e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOE—schizophrenia	4.71e-06	3.8e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOA1—schizophrenia	4.69e-06	3.79e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—AKT1—schizophrenia	4.65e-06	3.76e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOA1—schizophrenia	4.65e-06	3.76e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TP53—schizophrenia	4.33e-06	3.5e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AKT1—schizophrenia	4.17e-06	3.37e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—AKT1—schizophrenia	3.78e-06	3.06e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TP53—schizophrenia	3.66e-06	2.96e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AKT1—schizophrenia	3.66e-06	2.96e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AKT1—schizophrenia	3.09e-06	2.5e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—EP300—schizophrenia	2.94e-06	2.38e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—EP300—schizophrenia	2.71e-06	2.19e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—EP300—schizophrenia	2.68e-06	2.17e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AKT1—schizophrenia	1.78e-06	1.44e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AKT1—schizophrenia	1.64e-06	1.32e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AKT1—schizophrenia	1.62e-06	1.31e-05	CbGpPWpGaD
